BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2035 related articles for article (PubMed ID: 26422793)

  • 1. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome.
    Jungbauer CG; Birner C; Jung B; Buchner S; Lubnow M; von Bary C; Endemann D; Banas B; Mack M; Böger CA; Riegger G; Luchner A
    Eur J Heart Fail; 2011 Oct; 13(10):1104-10. PubMed ID: 21846754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
    Lobato GR; Lobato MR; Thomé FS; Veronese FV
    Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.
    Park M; Hsu CY; Go AS; Feldman HI; Xie D; Zhang X; Mifflin T; Waikar SS; Sabbisetti VS; Bonventre JV; Coresh J; Nelson RG; Kimmel PL; Kusek JW; Rahman M; Schelling JR; Vasan RS; Liu KD; ;
    Clin J Am Soc Nephrol; 2017 May; 12(5):761-771. PubMed ID: 28254771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyl-ß-D-glucosaminidase is predictive of mortality in chronic heart failure: a 10-year follow-up.
    Strack C; Bauer S; Hubauer U; Ücer E; Birner C; Luchner A; Maier L; Jungbauer C
    Biomark Med; 2021 Sep; 15(13):1143-1153. PubMed ID: 34397265
    [No Abstract]   [Full Text] [Related]  

  • 6. N-acetyl-b-D-glucosaminidase: A potential cardiorenal biomarker with a relevant impact on ICD shock therapies and mortality.
    Allgaier R; Strack C; Wallner S; Hubauer U; Uecer E; Lehn P; Keyser A; Luchner A; Maier L; Jungbauer C
    Nephrology (Carlton); 2020 Dec; 25(12):888-896. PubMed ID: 32841436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
    Opotowsky AR; Baraona FR; Mc Causland FR; Loukas B; Landzberg E; Landzberg MJ; Sabbisetti V; Waikar SS
    Heart; 2017 Mar; 103(6):434-442. PubMed ID: 27670967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of renal tubular damage in chronic heart failure.
    Damman K; Masson S; Hillege HL; Maggioni AP; Voors AA; Opasich C; van Veldhuisen DJ; Montagna L; Cosmi F; Tognoni G; Tavazzi L; Latini R
    Eur Heart J; 2011 Nov; 32(21):2705-12. PubMed ID: 21666249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study.
    Brankovic M; Akkerhuis KM; van Boven N; Anroedh S; Constantinescu A; Caliskan K; Manintveld O; Cornel JH; Baart S; Rizopoulos D; Hillege H; Boersma E; Umans V; Kardys I
    Kidney Int; 2018 Apr; 93(4):952-960. PubMed ID: 29191357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
    Hsu CY; Xie D; Waikar SS; Bonventre JV; Zhang X; Sabbisetti V; Mifflin TE; Coresh J; Diamantidis CJ; He J; Lora CM; Miller ER; Nelson RG; Ojo AO; Rahman M; Schelling JR; Wilson FP; Kimmel PL; Feldman HI; Vasan RS; Liu KD; ;
    Kidney Int; 2017 Jan; 91(1):196-203. PubMed ID: 28029431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women.
    Scherzer R; Lin H; Abraham A; Thiessen-Philbrook H; Parikh CR; Bennett M; Cohen MH; Nowicki M; Gustafson DR; Sharma A; Young M; Tien P; Jotwani V; Shlipak MG
    Nephrol Dial Transplant; 2016 Sep; 31(9):1478-85. PubMed ID: 26754833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
    Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
    Ahmad T; Jackson K; Rao VS; Tang WHW; Brisco-Bacik MA; Chen HH; Felker GM; Hernandez AF; O'Connor CM; Sabbisetti VS; Bonventre JV; Wilson FP; Coca SG; Testani JM
    Circulation; 2018 May; 137(19):2016-2028. PubMed ID: 29352071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.
    Sokolski M; Zymliński R; Biegus J; Siwołowski P; Nawrocka-Millward S; Todd J; Yerramilli MR; Estis J; Jankowska EA; Banasiak W; Ponikowski P
    Eur J Heart Fail; 2017 Jun; 19(6):760-767. PubMed ID: 28133864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.
    Emmens JE; Ter Maaten JM; Matsue Y; Metra M; O'Connor CM; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JG; Givertz MM; Bloomfield DM; Dittrich HC; Todd J; van Veldhuisen DJ; Hillege HL; Damman K; van der Meer P; Voors AA
    Eur J Heart Fail; 2016 Jun; 18(6):641-9. PubMed ID: 26511274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
    Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
    Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C.
    Zamora E; Lupón J; de Antonio M; Vila J; Peñafiel J; Galán A; Urrutia A; Domingo M; Bayes-Genis A
    Clin Chem; 2014 Mar; 60(3):481-9. PubMed ID: 24255081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 102.